Endometriosis: a saliva test soon available free of charge to detect the disease in certain patients

The High Authority for Health (HAS) announced on Friday its green light for the management of a saliva test in order to diagnose this pathology in certain women, via an exemption system. The Lyon biotech Ziwig now has a clinical study protocol considered sufficiently solid, “HAS is in favor of exceptional financial support for Endotest”via a package called “innovation”, “to allow certain patients to access it as quickly as possible”she said in a press release.

A chronic disease affecting around one in ten women, endometriosis usually results in severe pain during periods and/or fertility problems. Even today, it is diagnosed, often by chance, with an average delay of seven years. Thanks to its saliva test “ simple and reliable », Ziwig hopes to revolutionize the care of affected women.

Clinical study

HAS, however, awaits additional results before a possible “ broad and lasting reimbursement. Because if this test displays “ encouraging first clinical results (…), a non-invasive nature and a potential to cover a medical need which is not there”the data available until then were judged “insufficient” by the health authority. “The clinical study carried out in this respect will make it possible to provide early and secure access to the test and to collect missing data for future evaluation for common law treatment”explains the HAS.